Healthcare

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Axogen Inc. (NASDAQ:AXGN) reported that  Flynn James E has picked up 1,838,225 of common stock as of 2016-12-15. The acquisition brings the aggregate amount owned by Flynn James E to a total of 1,838,225 representing...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Authentidate Holding Corp. (OTCMKTS:ADAT) reported that Roshan Hanif A has picked up 970,160 of common stock as of 2017-03-24. The acquisition brings the aggregate amount owned by Roshan Hanif A to a total of 970,160...

When billionaire biotech entrepreneur Dr. Philip Frost, Chairman of Opko Health Inc. (NASDAQ:OPK), and Dr. Stephen Gillis, managing director of renowned biotech fund Arch Venture Partners, team up to take a position in a young biotech company, markets take notice. The recent gains in VBI Vaccines, Inc. - Ordinary Shares...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Intellia Therapeutics Inc. (NASDAQ:NTLA) reported that Caribou Biosciences, Inc. has picked up 5,593,846 of common stock as of 2017-02-28. The acquisition brings the aggregate amount owned by Caribou Biosciences, Inc. to a total of 5,593,846 ...

Some of the biggest biotechnology winners of 2017 so far are cannabis stocks. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a $3 billion pharmaceutical cannabis company and probably the most well known company in this subsector of healthcare, is up around 7% since the start of the year. Zynerba Pharmaceuticals Inc...